These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21807532)

  • 21. Tolerance, not immunity, crucially depends on IL-2.
    Malek TR; Bayer AL
    Nat Rev Immunol; 2004 Sep; 4(9):665-74. PubMed ID: 15343366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
    Li CR; Deiro MF; Godebu E; Bradley LM
    J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
    Chetoui N; Boisvert M; Gendron S; Aoudjit F
    Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmented IL-7 signaling during viral infection drives greater expansion of effector T cells but does not enhance memory.
    Sun JC; Lehar SM; Bevan MJ
    J Immunol; 2006 Oct; 177(7):4458-63. PubMed ID: 16982881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospect of IL-2, IL-7, IL-15 and IL-21 for HIV immune-based therapy.
    Diallo M; Zheng Y; Chen X; He Y; Zhou H; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1037-45. PubMed ID: 22169717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigallocatechin-3-gallate inhibits expression of receptors for T cell regulatory cytokines and their downstream signaling in mouse CD4+ T cells.
    Wang J; Pae M; Meydani SN; Wu D
    J Nutr; 2012 Mar; 142(3):566-71. PubMed ID: 22323768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.
    Penaranda C; Kuswanto W; Hofmann J; Kenefeck R; Narendran P; Walker LS; Bluestone JA; Abbas AK; Dooms H
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12668-73. PubMed ID: 22733744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal integration by Akt regulates CD8 T cell effector and memory differentiation.
    Kim EH; Sullivan JA; Plisch EH; Tejera MM; Jatzek A; Choi KY; Suresh M
    J Immunol; 2012 May; 188(9):4305-14. PubMed ID: 22467649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Timing of Stimulation and IL-2 Signaling Regulate Secondary CD8 T Cell Responses.
    Khan SH; Martin MD; Starbeck-Miller GR; Xue HH; Harty JT; Badovinac VP
    PLoS Pathog; 2015 Oct; 11(10):e1005199. PubMed ID: 26431533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine control of memory T-cell development and survival.
    Schluns KS; Lefrançois L
    Nat Rev Immunol; 2003 Apr; 3(4):269-79. PubMed ID: 12669018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.
    Obar JJ; Molloy MJ; Jellison ER; Stoklasek TA; Zhang W; Usherwood EJ; Lefrançois L
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):193-8. PubMed ID: 19966302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eomesodermin driven IL-10 production in effector CD8
    Reiser J; Sadashivaiah K; Furusawa A; Banerjee A; Singh N
    Cell Immunol; 2019 Jan; 335():93-102. PubMed ID: 30528350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and maintenance of memory CD4(+) T Cells.
    van Leeuwen EM; Sprent J; Surh CD
    Curr Opin Immunol; 2009 Apr; 21(2):167-72. PubMed ID: 19282163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Maintenance of Acquired Gene Expression Programs during Memory CD8 T Cell Homeostasis.
    Abdelsamed HA; Zebley CC; Youngblood B
    Front Immunol; 2018; 9():6. PubMed ID: 29403491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics.
    Osinalde N; Sanchez-Quiles V; Akimov V; Guerra B; Blagoev B; Kratchmarova I
    Proteomics; 2015 Jan; 15(2-3):520-31. PubMed ID: 25142963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-2/anti-IL-2 antibody complex enhances vaccine-mediated antigen-specific CD8+ T cell responses and increases the ratio of effector/memory CD8+ T cells to regulatory T cells.
    Mostböck S; Lutsiak ME; Milenic DE; Baidoo K; Schlom J; Sabzevari H
    J Immunol; 2008 Apr; 180(7):5118-29. PubMed ID: 18354238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.
    Nguyen TP; Bazdar DA; Mudd JC; Lederman MM; Harding CV; Hardy GA; Sieg SF
    J Leukoc Biol; 2015 Jun; 97(6):1139-46. PubMed ID: 25784743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cytokines in T-cell memory in health and disease.
    Raeber ME; Zurbuchen Y; Impellizzieri D; Boyman O
    Immunol Rev; 2018 May; 283(1):176-193. PubMed ID: 29664568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 family cytokines: An overview of genes, expression, signaling and functional roles in teleost.
    Zhang Y; Su J
    Dev Comp Immunol; 2023 Apr; 141():104645. PubMed ID: 36696924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.
    Williams MA; Tyznik AJ; Bevan MJ
    Nature; 2006 Jun; 441(7095):890-3. PubMed ID: 16778891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.